SCHEMBL4848280

SCHEMBL4848280

CCCCOc1ccccc1C=CC(=O)c1cc(-c2cc(C)cc(C)c2)ccc1OCCN(C)C

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AR P10275 2/20 0.46
SYK P43405 2/20 0.42
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 2/20 0.41
ESR1 P03372 1/20 0.40
BCHE P06276 1/20 0.40
ACHE P22303 1/20 0.40
PTPN11 Q06124 3/20 0.39
KEAP1 Q14145 1/20 0.39
NFE2L2 Q16236 1/20 0.39
SLC6A9 P48067 1/20 0.39
CYSLTR2 Q9NS75 1/20 0.39
CYSLTR1 Q9Y271 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
GBA1 P04062 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
ATM Q13315 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4855081 1.00 AR (0.46) ARSYKKDM4EALDH1A1ESR1
SCHEMBL4852245 0.95 SYK (0.45) ARSYKKDM4EALDH1A1BCHE
SCHEMBL4849808 0.95 SYK (0.45) ARSYKKDM4EALDH1A1BCHE
SCHEMBL4853093 0.94 KDM4E (0.47) ARSYKKDM4EALDH1A1BCHE
SCHEMBL4849704 0.94 KDM4E (0.47) ARSYKKDM4EALDH1A1BCHE
SCHEMBL4853937 0.93 AR (0.49) ARSYKKDM4EALDH1A1ESR1
SCHEMBL4845755 0.93 AR (0.49) ARSYKKDM4EALDH1A1ESR1
SCHEMBL4848288 0.93 AR (0.41) ARSYKKDM4EALDH1A1ESR1
SCHEMBL4855031 0.89 KDM4E (0.48) ARSYKKDM4EALDH1A1BCHE
SCHEMBL4847178 0.89 KDM4E (0.48) ARSYKKDM4EALDH1A1BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed
EP-1515940-A2 AMINOALKOXY-FUNCTIONAL CHALCONES Lica Pharmaceuticals A/S (DK) 2005-03-23 EP disclosed
WO-2003097574-A2 AMINOALKOXY-FUNCTIONAL CHALCONES LICA PHARMACEUTICALS A/S (DK) 2003-11-27 WO disclosed